Lava Therapeutics
在场
Lava Therapeutics 是一家在股票代码 LVTX (NL) 下上市的公司。
高管
查看带有其 17 名主要高管的组织结构图
Lava Therapeutics 搜索最多的简介
高管在Lava Therapeutics变化
- Sumeet Ambarkhane已作为Executive Medical Director加入公司 (新闻发布的2022六月16号).
- James Noble已作为Director加入公司 (新闻发布的2022六月16号).
- Wouter Van Hunnik已作为Vice President and Head of Human Resources加入公司 (新闻发布的2021十一月10号).
创建提醒
跟踪 Lava Therapeutics 的高管变动
生物技术
Lava Therapeutics 拥有 2,050 家竞争者，其中包括 Neptune Wellness Solutions (加拿大)、Inivata (美国(美洲)) 和 Biogroup-LCD (法国)。
Popular M&A news in 生物技术
- PicnicHealth 刚刚宣布为 60 筹款数百万美元。 (公布2022七月1号).
- Visby Medical 凭借他的 100 百万美元筹款活动成为了独角兽。 (公布2022七月1号).
- ReCode Therapeutics 刚刚宣布为 200 筹款数百万美元。 (公布2022六月30号).
生物技术 行业的其他推荐联系人
消息
Lava Therapeutics 的最新新闻稿
- LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Program, LAVA-051, in Chronic Lymphocytic Leukemia and Multiple Myeloma Patients - LAVA Therapeutics N.V.
- LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Program, LAVA-051, in Chronic Lymphocytic Leukemia and Multiple Myeloma Patients - LAVA Therapeutics N.V.
- LAVA Therapeutics Announces Two Appointments to its Board of Directors - LAVA Therapeutics N.V.
- LAVA Therapeutics Announces Two Appointments to its Board of Directors - LAVA Therapeutics N.V.
- LAVA Therapeutics to Participate at the Jefferies Healthcare Conference - LAVA Therapeutics N.V.
- LAVA Therapeutics to Present Initial Phase 1/2a Clinical Trial Dose Escalation Data of LAVA-051 in Chronic Lymphocytic Leukemia and Multiple Myeloma Patients at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - LAVA Therapeutics N.V.
- LAVA Therapeutics Announces Annual Meeting of Shareholders - LAVA Therapeutics N.V.
- LAVA Therapeutics to Participate at the Jefferies Healthcare Conference - LAVA Therapeutics N.V.
- LAVA Therapeutics to Present Initial Phase 1/2a Clinical Trial Dose Escalation Data of LAVA-051 in Chronic Lymphocytic Leukemia and Multiple Myeloma Patients at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - LAVA Therapeutics N.V.
- LAVA Therapeutics Announces Annual Meeting of Shareholders - LAVA Therapeutics N.V.
- View more press releases Close
通过电子邮件
